Individual Dopaminergic Neurons Show Raised Iron Levels in Parkinson Disease
Neurol 68:1820-1825, Oakley,A.E.,et al, 2007
Predictors of Diagnosis in Huntington Disease
Neurol 68:1710-1717, Langbehn,D.R.,et al, 2007
Quantifying the Risks and Benefits of Natalizumab in Relapsing Multiple Sclerosis
Neurol 68:1524-1528, Dorsey,E.R.,et al, 2007
A 46-Year-Old Woman With Severe Weakness Following Acute Respiratory Distress Syndrome
Neurol 68:1529-1535, Waclawik,A.J.,et al, 2007
Investigating Suspected Cerebral Venous Thrombosis
BMJ 334:794-795, Smit,R. &Hourihan,M.D., 2007
The Efficacy and Safety of Enoxaparin Versus Unfractionated Heparin for the Prevention of Venous Thromboembolism After Acute Ischaemic Stroke (PREVAIL Study): An Open-Label Randomised Comparison
Lancet 369:1347-1355, Sherman,D.G.,et al, 2007
MRI Outcomes in a Placebo-Controlled Trial of Natalizumab in Relapsing MS
Neurol 68:1390-1401, Miller,D.H.,et al, 2007
Refractory Neurosarcoidosis Responsive to Infliximab
Pract Neurol 7:112-115, Kobylecki,C. &Shaunak,S., 2007
Combining Multiple Approaches for the Secondary Prevention of Vascular Events After Stroke: A Quantitative Modeling Study
Stroke 38:1881-1885,1736, Hackam,D.D. &Spence,J.D., 2007
Short-Term Risk for Stroke Is Doubled in Persons With Newly Treated Type 2 Diabetes Compared With Persons Without Diabetes: A Population-Based Cohort Study
Stroke 38:1739-1743, Jeerakathil,T.,et al, 2007
Repetitive Strain Injury
Lancet 369:1815-1822, van Tulder,M.,et al, 2007
Back Surgery -- Who Needs It?
NEJM 356:2239-2245, Deyo,R.A., 2007
Recurrence of Afebrile Status Epilepticus in a Population-Based Study in Rochester, Minnesota
Neurol 69:73-78, Hesdorffer,D.C.,et al, 2007
Prednisolone Does Not Reduce Withdrawal Headache
Neurol 69:26-31, Boe,M.G., et al, 2007
Epidemic Meningitis, Meningococcaemia, and Neisseria meningitidis
Lancet 369:2196-2210, Stephens,D.S.,et al, 2007
Amyotrophic Lateral Sclerosis
Lancet 369:2031-2041, Mitchell,J.D. & Borasio,G.D., 2007
Prothombotic Mutations as Risk Factors for Cryptogenic Ischemic Cerebrovascular Events in Young Subjects With Patent Foramen Ovale
Stroke 38:2070-2073, Botto,N.,et al, 2007
The Metabolic Syndrome and Stroke: Potential Treatment Approaches
Stroke 38:2196-2203, Arenillas,J.F.,et al, 2007
Natalizumab for Multiple Sclerosis
NEJM 356:2622-2629, Ransohoff,R.M., 2007
Arteriovenous Malformations of the Brain
NEJM 356:2704-2712, Friedlander,R.M., 2007
Risk Factors for the Development of Pedal Edema in Patients Using Pramipexole
Arch Neurol 64:820-824, Kleiner-Fisman,G. &Fisman,D.N., 2007
Multiple Ischemic Strokes Associated With Use of Recombinant Activated Factor VII
Arch Neurol 64:879-881, Libman,R.B.,et al, 2007
Efficacy of Folic Acid Supplementation in Stroke Prevention: A Meta-Analysis
Lancet 369:1876-1882,1841, Wang,X.,et al, 2007
Causative Factors and Epidemiology of Bilateral Vestibulopathy in 255 Patients
Ann Neurol 61:524-532, Zingler,V.C.,et al, 2007
Paroxysmal Extreme Pain Disorder (Previously Familial Rectal Pain Syndrome)
Neurol 69:586-595, Fertleman,C.R.,et al, 2007
Independent Predictors of Stroke in Patients with Atrial Fibrillation
Neurol 69:546-554, The Stroke Risk in Atrial Fibrillation Working Group, 2007
Diffusion-Weighted Imaging-Negative Patients With Transient Ischemic Attack Are at Risk of Recurrent Transient Events
Stroke 38:2367-2369, Boulanger,J.-M.,et al, 2007
Frequent Atrial Premature Beats Predict Paroxysmal Atrial Fibrillation in Stroke Patients
Stroke 38:2292-2294, Wallmann,D.,et al, 2007
Hemorrhage After Thrombolytic Therapy for Stroke: The Clinically Relevant Number Needed to Harm
Stroke 38:2279-2283, Saver,J.L., 2007
From Sea to Shining Sea: What Is It About Where You Live and Your Stroke Risk?
Stroke 38:2210-2212, Howard,V.J., 2007
Whipples Disease
NEJM 356:55-66, Fenollar,F.,et al, 2007
Multiple Sclerosis After Infectious Mononucleosis
Arch Neurol 64:72-75, Nielsen,T.R.,et al, 2007
Phenylpropanolamine Contained in Cold Remedies and Risk of Hemorrhagic Stroke
Neurol 68:146-149, Yoon,B.W.,et al, 2007
Valvular Heart Disease and the Use of Dopamine Agonists for Parkinsons Disease
NEJM 356:39-46, Zanettini,R.,et al, 2007
Vertebral Artery Hypoplasia: A Predisposing Factor for Posterior Circulation Stroke?
Neurol 68:65-67, Perren,F.,et al, 2007
Depressive Symptoms and Risk of Stroke: The Framingham Study
Stroke 38:16-21, Salaycik,K.J.,et al, 2007
Hemostatic Drug Therapies for Acute, Nontraumatic Intracerebral Hemorrhage
Stroke 38:204-205, Al-Shahi,R. &You,H., 2007
Antithrombotic and Interventional Treatment Options in Cardioembolic Transient Ischaemic Attack and Ischaemic Stroke
JNNP 78:14-24, McCabe,D.J.H. &Rakhit,R.D., 2007
Subarachnoid Haemorrhage
Lancet 369:306-318, van Gijn,J.,et al, 2007
Validation and Refinement of Scores to Predict Very Early Stroke Risk After Transient Ischaemic Attack
Lancet 369:283-292,251, Johnston,S.C.,et al, 2007
An 85-Year-Old Man With Chronic Lymphocytic Leukemia and Altered Mental Status
Neurol 68:460-467, Tyler,K.L.,et al, 2007
Right-to-Left Shunt and Lacunar Stroke in Patients Without Hypertension and Diabetes
Neurol 68:528-531, Ueno,Y.,et al, 2007
Cardiac Valve Regurgitation With Pergolide Compared With Nonergot Agonsits in Parkinson Disease
Arch Neurol 64:377-380, Dewey,R.B.,Jr, et al, 2007
Secondary Stroke Prevention With Ximelagatran Versus Warfarin in Patients With Atrial Fibrillation: Pooled Analysis of SPORTIF III and V Clinical Trials
Stroke 38:874-880, Akins,P.T.,et al, 2007
Febrile Seizures
BMJ 334:307-11, Sadleir,L.G. &Scheffer,I.E., 2007
Perioperative Stroke
NEJM 356:706-713, Selim,M., 2007
Aspergillus Meningitis in Sri Lanka -- A Post-Tsunami Effect?
NEJM 356:754-756, Gunaratne,P.S.,et al, 2007
Neurocysticercosis Uncovered by Single-Dose Albendazole
NEJM 356:1277-1278, Garcia,H.H.,et al, 2007
Gender Differences in Parkinsons Disease
JNNP 78:819-824,787, Haaxma,C.A.,et al, 2007
Corticosteroids for Acute Bacterial Meningitis
NEJM 357:2507-2509, Greenwood,B.M., 2007